A randomized study of carbon dioxide management during hypothermic cardiopulmonary bypass

• Published in: Anesthesiology (Philadelphia) 1990, Vol.72 (1), p.7-15
• Main Authors: BASHEIN, G, TOWNES, B. D, NESSLY, M. L, BLEDSOE, S. W, HORNBEIN, T. F, DAVIS, K. B, GOLDSTEIN, D. E, COPPEL, D. B
• Format: Article
• Language: English
• Subjects: Anesthesia; Anesthesia depending on type of surgery; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Biological and medical sciences; Carbon Dioxide - blood; Cardiopulmonary Bypass; Humans; Hypothermia, Induced; Medical sciences; Mental Disorders - prevention & control; Nervous System Diseases - prevention & control; Partial Pressure; Postoperative Complications - prevention & control; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Thoracic and cardiovascular surgery. Cardiopulmonary bypass
• ISSN: 0003-3022; 1528-1175
• DOI: 10.1097/00000542-199001000-00003

Eighty-six patients undergoing coronary artery bypass graft (n = 63) or intracardiac (n = 23) surgery were randomly assigned with respect to the target value for PaCO2 during cardiopulmonary bypass. In 44 patients the target PaCO2 was 40 mmHg, measured at the standard electrode temperature of 37 degrees C, while in 42 patients the target PaCO2 was 40 mmHg, corrected to the patient's rectal temperature (lowest value reached: mean 30.1, SD 1.9 degrees C). Other salient features of bypass management include use of bubble oxygenators without arterial filtration, flows of 1.8-2.4 l.min-1.m-2, mean hematocrit of 23%, and mean arterial blood pressure of approximately 70 mmHg, achieved by infusion of phenylephrine or sodium nitroprusside. Neuropsychologic function was assessed with series of tests administered on the day prior to surgery, just before discharge from the hospital (mean 8.0, SD 5.8 days postoperatively, n = 82), and again 7 months later (mean 220.7, SD 54.4 days postoperatively, n = 75). The scores at 8 days showed wide variability and generalized impairment unrelated to the PaCO2 group or to hypotension during cardiopulmonary bypass. At 7 months no significant difference was observed in neuropsychologic performance between the PaCO2 groups. Regarding cardiac outcome, there were no significant differences between groups in the appearance of new Q-waves on the electrocardiogram, the postoperative creatine kinase-MB fraction, the need for inotropic or intraaortic balloon pump support, or the length of postoperative ventilation or intensive care unit stay. These findings support the hypothesis that CO2 management during cardiopulmonary bypass at moderate hypothermia has no clinically significant effect on either neurobehavioral or cardiac outcome.